0
0
6/9/23 at 3:04pm
Organization
Daily Mail
Author
Caitlin Tilley
41 words
0
Comments
Members of the agency's Antimicrobial Drugs Advisory Committee backed the use of Sanofi and partner AstraZeneca's experimental antibody, nirsevimab, for infants in a 21-0 vote on Thursday.
You are the first to view
https://www.dailymail.co.uk/health/article-12178075/FDA-panel-backs-antibody-protect-infants-against-RSV-injectable-drug-cuts-ward-visits-78.html
Create an account
or login to join the discussion